Boxer Capital, LLC, 10% Owner at Mirati Therapeutics, Inc. (MRTX), bought 50,000 shares at $97.50 ($4.9M) on 2020-01-10, disclosed to the SEC on 2020-01-14.
Open-market purchase of $4.9M MRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| TNGX | BUY | 2022-10-13 | $1.0M | — | Filing → |
| ITOS | SELL | 2022-03-18 | $40.6M | — | Filing → |
| ODT | SELL | 2021-11-24 | $624K | — | Filing → |